IRIS
PEPE, MARTINO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.649
AS - Asia 2.321
EU - Europa 1.720
SA - Sud America 545
AF - Africa 124
OC - Oceania 6
AN - Antartide 1
Totale 10.366
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.558
SG - Singapore 1.013
CN - Cina 429
BR - Brasile 416
IT - Italia 416
DE - Germania 338
HK - Hong Kong 273
RU - Federazione Russa 223
FR - Francia 206
VN - Vietnam 178
FI - Finlandia 168
GB - Regno Unito 104
SE - Svezia 101
IN - India 77
AR - Argentina 55
CA - Canada 50
ID - Indonesia 50
BD - Bangladesh 42
IQ - Iraq 38
PK - Pakistan 36
CI - Costa d'Avorio 34
NL - Olanda 32
TR - Turchia 31
JP - Giappone 25
MX - Messico 24
ZA - Sudafrica 23
AT - Austria 21
CO - Colombia 19
EC - Ecuador 18
TN - Tunisia 17
PH - Filippine 16
MA - Marocco 15
UZ - Uzbekistan 15
BE - Belgio 14
ES - Italia 14
UA - Ucraina 14
PL - Polonia 13
VE - Venezuela 13
MY - Malesia 12
SA - Arabia Saudita 12
JO - Giordania 11
CZ - Repubblica Ceca 10
AE - Emirati Arabi Uniti 9
LT - Lituania 9
PE - Perù 8
AZ - Azerbaigian 7
EG - Egitto 7
IE - Irlanda 7
PY - Paraguay 7
AU - Australia 6
IL - Israele 6
KE - Kenya 6
CH - Svizzera 5
CL - Cile 5
DO - Repubblica Dominicana 5
KZ - Kazakistan 5
IR - Iran 4
JM - Giamaica 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
DZ - Algeria 3
ET - Etiopia 3
OM - Oman 3
PA - Panama 3
QA - Qatar 3
TW - Taiwan 3
AL - Albania 2
BF - Burkina Faso 2
BG - Bulgaria 2
BH - Bahrain 2
BY - Bielorussia 2
CG - Congo 2
GE - Georgia 2
GR - Grecia 2
HU - Ungheria 2
KH - Cambogia 2
KR - Corea 2
LB - Libano 2
LY - Libia 2
NP - Nepal 2
PT - Portogallo 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BO - Bolivia 1
CM - Camerun 1
DK - Danimarca 1
EE - Estonia 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
KG - Kirghizistan 1
KW - Kuwait 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
Totale 10.353
Salva come PNG Salva come JPEG
Città #
Dallas 2.631
Singapore 547
Ashburn 428
San Jose 362
Hong Kong 270
Fairfield 223
Munich 161
Beijing 160
Helsinki 134
Chandler 133
Woodbridge 119
Houston 98
New York 95
Lauterbourg 90
Council Bluffs 85
Bari 81
Falkenstein 81
Los Angeles 79
Seattle 78
Cambridge 74
Nyköping 65
Wilmington 59
Ho Chi Minh City 52
Ann Arbor 47
Hanoi 45
Buffalo 42
Jakarta 42
Santa Clara 41
Abidjan 34
Marseille 34
São Paulo 29
Chicago 28
Boardman 27
Xi'an 23
Frankfurt am Main 22
London 21
Milan 20
Tokyo 20
Turku 20
Baghdad 19
Lawrence 19
Roxbury 19
Nuremberg 18
Montreal 17
Jacksonville 16
Nanjing 16
Rio de Janeiro 16
Brooklyn 15
Poplar 15
Tashkent 15
Moscow 14
Atlanta 13
Naples 13
Rome 13
Shenzhen 13
Brussels 12
Da Nang 12
Denver 12
Johannesburg 12
San Diego 12
Stockholm 12
Ankara 11
Des Moines 11
Karachi 11
Lahore 11
Manchester 11
Salvador 11
Secaucus 11
Amman 10
Florence 9
Orem 9
Paris 9
Phoenix 9
Salt Lake City 9
Toronto 9
Warsaw 9
Buenos Aires 8
Dong Ket 8
Haiphong 8
San Francisco 8
Vienna 8
Belo Horizonte 7
Bisceglie 7
Bogotá 7
Brasília 7
Campinas 7
Charlotte 7
Chennai 7
Dearborn 7
Dublin 7
Düsseldorf 7
Foggia 7
Inglewood 7
Porto Alegre 7
Princeton 7
Shenyang 7
The Dalles 7
Amsterdam 6
Baku 6
Barletta 6
Totale 7.243
Salva come PNG Salva come JPEG
Nome #
Anemia as a risk factor for disease progression in patients admitted for COVID-19: data from a large, multicenter cohort study 400
Sailing Across Contraception, Pregnancy, and Breastfeeding: The Complex Journey of Women with Cardiomyopathies 311
A novel multidisciplinary approach in an LMNA-mutated patient: the importance of considering the overall clinical picture for the early diagnosis 272
Comparative one-month safety and effectiveness of five leading new-generation devices for transcatheter aortic valve implantation 252
Giant Cardiac Fibroma in a Completely Asymptomatic Teenager 230
No Reflow-phenomenon: from Current State of the Art to Future Perspectives 225
Impact of Predilation Before Transcatheter Aortic Valve Implantation with New-Generation Devices 222
Emergency coronary and peripheral arteries combined with percutaneous intervention in the elderly: success or therapeutic excess? 211
A Striking Coronary Artery Pattern in a Grown-Up Congenital Heart Disease Patient 209
Functional study of a KCNH2 mutant: Novel insights on the pathogenesis of the LQT2 syndrome 206
Prime time for the sweet spot in timing of coronary invasive approach in patients with non-ST elevation myocardial infarction 201
Comparison of ProGlide vs. Prostar in patients undergoing transcatheter aortic valve implantation 196
Percutaneous coronary intervention for unprotected left main disease in very high risk patients: safety of drug-eluting stents 195
Remote ischemic preconditioning in isolated valve intervention. A pooled meta-analysis 193
Reverse takotsubo cardiomyopathy followed by left ventricle outflow tract obstruction: A dangerous relay race 182
Time-dependent benefits of pre-treatment with new oral P2Y12 -inhibitors in patients addressed to primary PCI for acute ST-elevation myocardial infarction 182
How to Approach a Spontaneous Coronary Artery Dissection: An Up-To-Date 180
'Broken-heart' syndrome: ventricular septal perforation in a takotsubo cardiomyopathy 175
STEMI and NSTEMI ACS in a 30-Year-Old Patient: An Extremely Rare Complication of a Left Atrial Myxoma. 170
Cardiomyocyte VEGFR-1 activation by VEGF-B induces compensatory hypertrophy and preserves cardiac function after myocardial infarction 169
Cardiogenic Shock following Acute Myocardial Infarction: What's New? 169
Role of plasma glucose level on myocardial perfusion in ST-segment elevation myocardial infarction patients 165
Life-threatening acute myocardial infarction due to left main dissection during radiofrequency transcatheter ablation of atrial tachycardia 164
Correlation between endothelial dysfunction and myocardial damage in acute phase of Tako-Tsubo cardiomyopathy: brachial flow mediated dilation as a potential marker for assessment of patient with Tako-Tsubo. 160
Massive stent thrombosis during active ulcerative colitis: the tricky balance between manifest hemorrhagic and concealed thrombotic risk 157
Intramyocardial VEGF-B167 gene delivery delays the progression towards congestive failure in dogs with pacing-induced dilated cardiomyopathy 148
Omega-3 fatty acids for the prevention of myocardial infarction and arrhythmias 138
Reverse changes in cardiac substrate oxidation in dogs recovering from heart failure 129
Importance of clinical suspicion and multidisciplinary management for early diagnosis of a cardiac laminopathy patient: A case report 124
Aortic coarctation: guidelines mismatch across the ocean 119
Th2-dependent cytokine release in patients treated with coronary angioplasty 116
Fractional flow reserve and intravascular scan as part of the coronary fistulas diagnostic process: Future perspectives 111
Aortic valve fibroelastoma presenting with myocardial infarction with non-obstructive coronary arteries (MINOCA): a case report and review of the literature 110
Pro-inflammatory cytokines as emerging molecular determinants in cardiolaminopathies 104
Assessing the Best Prognostic Score for Transcatheter Aortic Valve Implantation (from the RISPEVA Registry) 101
Missense and Non-Missense Lamin A/C Gene Mutations Are Similarly Associated with Major Arrhythmic Cardiac Events: A 20-Year Single-Centre Experience 99
Alex Plus Versus Xience Drug-Eluting Stents for Percutaneous Coronary Intervention in Routine Clinical Practice: A Propensity Score-Matched Analysis 97
Inflammatory bowel disease and acute coronary syndromes: From pathogenesis to the fine line between bleeding and ischemic risk. 94
A Young Patient Presenting with Dilated Cardiomyopathy and Renal Infarction during Treatment with Isotretinoin: Mere Coincidence or Serious Side Effect of a Drug Commonly Used in Adolescence? 93
Comparative effectiveness of Cangrelor in patients with acute coronary syndrome undergoing percutaneous coronary intervention: an observational investigation from the M.O.Ca. registry 93
Autoimmune diseases in patients undergoing percutaneous coronary intervention: A risk factor for in-stent restenosis? 92
Sudden cardiac death secondary to demonstrated reperfusion ventricular fibrillation in a woman with Takotsubo cardiomyopathy 92
Corrigendum to "A Striking Coronary Artery Pattern in a Grown-Up Congenital Heart Disease Patient" 91
Anticoagulation Therapy in Patients With Coronavirus Disease 2019: Results From a Multicenter International Prospective Registry (Health Outcome Predictive Evaluation for Corona Virus Disease 2019 [HOPE-COVID19]) 87
Role of Nuclear Lamin A/C in the Regulation of Nav1.5 Channel and Microtubules: Lesson From the Pathogenic Lamin A/C Variant Q517X 86
Infiammazione Th17 dipendente e attivazione metallo-proteasica dopo angioplastica coronarica. 86
Baseline, procedural and outcome features of patients undergoing transcatheter aortic valve implantation according to different body mass index categories 86
A concealed case of takotsubo syndrome as consequence of ab ingestis episode in a revascularized patient 84
Targeting unfolded protein response reverts ER stress and ER Ca2+ homeostasis in cardiomyocytes expressing the pathogenic variant of Lamin A/C R321X 84
Comparison of Outcomes of Transcatheter Aortic Valve Implantation in Patients ≥85 Years Versus Those <85 Years 83
Percutaneous exclusion of ascending aorta pseudoaneurysms: still an interventional challenge? 82
Prognostic value of 12-leads admission electrocardiogram in low-risk patients hospitalized for COVID-19 81
Late gadolinium enhancement role in arrhythmic risk stratification of patients with LMNA cardiomyopathy: results from a long-term follow-up multicentre study 81
Safety of reduced or absent antithrombotic therapy after left atrial appendage closure in patients affected by hereditary hemorrhagic telangiectasia and atrial fibrillation 76
Antithrombotic Therapy for Vascular Disease and Intervention: The Best Is Yet to Come? 76
Degenerative Severe Aortic Stenosis and Concomitant Coronary Artery Disease: What Is Changing in the Era of the "Transcatheter Revolution"? 73
Transcatheter Aortic Valve Replacement for Mixed Aortic Valve Disease: A Propensity Score-Adjusted Analysis From the RISPEVA Registry 72
COVID-19 and the impact of arterial hypertension-An analysis of the international HOPE COVID-19 Registry (Italy-Spain-Germany). 68
Clinical presentation, therapeutic approach, and outcome of young patients admitted for COVID-19, with respect to the elderly counterpart 67
Clinical profile and predictors of in-hospital mortality among older patients hospitalised for COVID-19 67
Comparative Effectiveness and Safety of Polymer-Free Biolimus-Eluting Stent and Durable Polymer Everolimus-Eluting Stent in All-Comer Patients Who Underwent Percutaneous Coronary Interventions 66
Clinical use of cangrelor: a real-world multicenter experience from South Italy 65
Anti-Inflammatory Therapy for Acute Coronary Syndromes: Is It Time for a Shift in the Treatment Paradigm? 64
Percutaneous Edge-to-Edge Transcatheter Mitral Valve Repair: Current Indications and Future Perspectives. 63
TAVI-CT score to evaluate the anatomic risk in patients undergoing transcatheter aortic valve implantation 61
Role of pre-operative embolization in carotid body tumor surgery according to Shamblin classification: A systematic review and meta-analysis 60
Chronic Oral Anticoagulation Therapy and Prognosis of Patients Admitted to Hospital for COVID-19: Insights from the HOPE COVID-19 Registry 59
MitraClip™ implantation plus left atrial appendage occlusion in a hereditary hemorrhagic telangiectasia patient 59
Transcatheter aortic valve implantation with the novel-generation Navitor device: Procedural and early outcomes 57
Transcatheter aortic valve implantation with Allegra: procedural and mid-term outcomes according to experience phase in a high-volume center 57
Does there exist an obesity paradox in COVID-19? Insights of the international HOPE-COVID-19-registry 54
Transcatheter aortic valve implantation in patients with age ≤70 years: experience from two leading structural heart disease centers 53
Use of cangrelor in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Study design and interim analysis of the ARCANGELO study 52
COVID-19 anosmia and gustatory symptoms as a prognosis factor: a subanalysis of the HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry 52
Renin-angiotensin system inhibitors effect before and during hospitalization in COVID-19 outcomes: Final analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry 52
Impact of Insulin-Treated and Noninsulin-Treated Diabetes Mellitus in All-Comer Patients Undergoing Percutaneous Coronary Interventions With Polymer-Free Biolimus-Eluting Stent (from the RUDI-FREE Registry) 51
Impact of Tirofiban on Serum Troponin Changes in Patients Undergoing Carotid Artery Stenting: A Propensity Matched Analysis 49
Minimally invasive approaches to primary cardiac tumors: A systematic review and meta-analysis 48
Sepsis of Patients Infected by SARS-CoV-2: Real-World Experience From the International HOPE-COVID-19-Registry and Validation of HOPE Sepsis Score 48
Prevalence and 30-Day Mortality in Hospitalized Patients With Covid-19 and Prior Lung Diseases 48
Long-Term Follow-Up of Transcatheter Aortic Valve Implantation With Portico Versus Evolut Devices 48
Uric Acid Induces a Proatherothrombotic Phenotype in Human Endothelial Cells by Imbalancing the Tissue Factor/Tissue Factor Pathway Inhibitor Pathway 48
Gender Differences in the Presentation and Outcomes of Hospitalized Patients With COVID-19 46
Predictors of poor prognosis in healthy, young, individuals with SARS-CoV-2 infections 45
The best way to transcatheter aortic valve implantation: from standard to new approaches 44
Impact of smoking on COVID-19 outcomes: a HOPE Registry subanalysis 43
Overall impact of tethering and of its symmetric and asymmetric subtypes on early and long-term outcome of transcatheter edge-to-edge repair of significant mitral valve regurgitation 43
Underlying heart diseases and acute COVID-19 outcomes 43
Thrombocytopenia Complicating Transcatheter Aortic Valve Implantation: Differences Between Two New-Generation Devices 41
Mortality risk assessment in Spain and Italy, insights of the HOPE COVID-19 registry 39
Unsupervised Machine Learning with Cluster Analysis in Patients Discharged after an Acute Coronary Syndrome: Insights from a 23,270-Patient Study 39
Prognostic Impact of Hyponatremia and Hypernatremia in COVID-19 Pneumonia. A HOPE-COVID-19 (Health Outcome Predictive Evaluation for COVID-19) Registry Analysis 38
Acute Hyperglycemia-Induced Injury in Myocardial Infarction 37
Impact of Institutional Monthly Volume of Transcatheter Edge-to-Edge Repair Procedures for Significant Mitral Regurgitation: Evidence from the GIOTTO-VAT Study 36
Incidence and Predictors of Cerebrovascular Accidents in Patients Who Underwent Transcatheter Mitral Valve Repair With MitraClip 36
Crossover balloon occlusion technique for access closure during transcatheter aortic valve implantation: a multicenter observational study 36
Impact of renal function on admission in COVID-19 patients: an analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID 19) Registry 36
Appraising features and outlook of women and men discharged after an acute coronary syndrome: evidence from the 23,700-patient PRAISE International Registry 35
The Novel FlexNav Delivery System for Transcatheter Aortic Valve Implantation With the Portico Device: A Case Series 34
Post-COVID-19 Symptoms and Heart Disease: Incidence, Prognostic Factors, Outcomes and Vaccination: Results from a Multi-Center International Prospective Registry (HOPE 2) 32
Totale 10.403
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.529
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.529
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202176 0 0 0 0 0 0 0 0 0 39 13 24
2021/2022192 22 4 2 4 10 26 16 11 14 18 25 40
2022/2023471 32 44 21 22 31 45 2 54 86 76 39 19
2023/2024319 21 50 22 26 35 80 8 13 10 12 9 33
2024/20251.925 93 20 80 130 78 148 289 176 98 107 221 485
2025/20266.860 514 224 3.014 469 475 291 547 210 641 475 0 0
Totale 10.824